AYTU Aytu BioPharma Inc
41,938
$3.21
$0.11
(3.55%)
| Watchers | 41,938 |
| 52-Wk Low | $1.38 |
| 52-Wk High | $3.50 |
| Market Cap | $17.87M |
| Volume | 9,486.00 |
| 52-Wk High | $3.50 |
| 52-Wk Low | $1.38 |
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register NowGlobe Newswire • about 1 month ago
MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024. The...
Share to Feed
MIAMI, April 02, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024...
Despite an already strong run, Aytu BioPharma, Inc. ( NASDAQ:AYTU ) shares have been powering on, with a gain of 25% in...
Q2 2024 operating income of $2.4 millionQ2 2024 net loss of $0.2 million and adjusted EBITDA1 of $5.1 millionQ2 2024 Rx Segment net revenue of $18.7 million, net income of $0.7 million, and adjusted...
DENVER, CO / ACCESSWIRE / February 7, 2024 / Aytu BioPharma, Inc. (the 'Company' or 'Aytu') (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its...
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
DENVER, CO / ACCESSWIRE / January 23, 2024 / Aytu BioPharma, Inc. (the Company or 'Aytu') (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that...